“anadys-pharmaceuticals” Archives

Entry Author Date Location
Using HIV as Model, Anadys Develops Drug Cocktail Ingredient for Hepatitis C 03/17/09 San Diego
Anadys Keeps Surging, as Hepatitis C Drug Data Trickles In 02/10/09 San Diego
ZymoGenetics Snags $1.1 Billion Partnership With Bristol-Myers For Hepatitis C Drug 01/12/09 Seattle
Sequenom Makes Buyout Offer, Anadys Zooms on Promising Results, Michael Robertson Gives iPod Last Rights, Forward Ventures Going Virtual, & More San Diego BizTech News 01/12/09 San Diego
Anadys Shares Boom on Hepatitis C Finding 01/08/09 San Diego
Hepatitis C Drug From Anadys Shows Quick Virus-Killing Punch 01/08/09 San Diego
Supersized Ambitions: VentiRx Aims to be Extra-Large Player in Cancer, Allergy Medicines 01/07/09 Seattle
FDA Gives Fast-Track Status to Anadys’ Hepatitis C Drug Candidate 12/03/08 San Diego
Biotech Survival Index: Cash Woes Creeping Up on San Diego Life Sciences Companies 11/18/08 San Diego
Anadys Drug Found Safe in Small Study, Aims to Contend in New Class of Hepatitis C Meds 11/01/08 San Diego
Alnylam–Isis Venture Regulus, Leader in MicroRNA Drugs, Aspires to Create New Paradigm of Treatments 10/24/08 San Diego
Page 2 of 2 « previous page